Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Metastatic Breast Cancer”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableStudy completedNCT01116869
What this trial is testing

China CellSearch Study

Who this might be right for
Metastatic Breast CancerBenign Breast Disease
Johnson & Johnson Medical, China 500
Early research (Phase 1)Study completedNCT02780401
What this trial is testing

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission

Who this might be right for
HER2/Neu NegativeNo Evidence of DiseaseOne or More Positive Axillary Nodes+8 more
University of Washington 32
Large-scale testing (Phase 3)Ended earlyNCT00908531
What this trial is testing

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Who this might be right for
Operable Breast Neoplasms
Danish Breast Cancer Cooperative Group 123
Testing effectiveness (Phase 2)Ended earlyNCT01332916
What this trial is testing

Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging

Who this might be right for
Breast CancerHealthy
Centre Francois Baclesse 60
Early research (Phase 1)Study completedNCT00674791
What this trial is testing

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Who this might be right for
Breast Cancer
Duke University 13
Large-scale testing (Phase 3)Study completedNCT00003010
What this trial is testing

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 334
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Not applicableActive Not RecruitingNCT05538000
What this trial is testing

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)

Who this might be right for
No Metastatic Breast Cancer
Institut de Cancérologie de Lorraine 50
Testing effectiveness (Phase 2)Study completedNCT01746225
What this trial is testing

Schedules of Nab-Paclitaxel in Metastatic Breast Cancer

Who this might be right for
Metastatic Breastcancer
ETOP IBCSG Partners Foundation 258
Testing effectiveness (Phase 2)Study completedNCT00425854
What this trial is testing

An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 50
Not applicableStudy completedNCT00005956
What this trial is testing

Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerGastric CancerOvarian Cancer
Duke University 3
Not applicableLooking for participantsNCT03646955
What this trial is testing

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Who this might be right for
Local Neoplasm RecurrenceDistantly Metastatic Malignant NeoplasmDeath+6 more
Danish Breast Cancer Cooperative Group 926
Not applicableStudy completedNCT00638391
What this trial is testing

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 1,600
Not applicableNot Yet RecruitingNCT06383663
What this trial is testing

Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer

Who this might be right for
Breast CancerIpsilateral Supraclavicular Lymph Node Metastasis
Sun Yat-sen University 452
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Testing effectiveness (Phase 2)Study completedNCT00847171
What this trial is testing

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT00087958
What this trial is testing

Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Who this might be right for
Breast Cancer
Sanofi 168
Not applicableApproved For MarketingNCT01240421
What this trial is testing

An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory

Who this might be right for
Metastatic Breast Cancer
Eisai Inc.
Testing effectiveness (Phase 2)Study completedNCT00709761
What this trial is testing

Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 60
Load More Results